India's Nifty falls on rising crude, traders eye select breakouts
Rising crude oil prices and weak global sentiment pushed Indian equities lower, confining the benchmark Nifty 50 to a tight trading range as investors pivot to stock-specific technical breakouts.
Indian equity markets closed sharply lower on July 14 as rising crude oil prices and weak global cues weighed heavily on sentiment. The Sensex dropped 561 points to 77,054, while the Nifty 50 fell 159 points to settle at 24,052.
Selling pressure concentrated in the IT, auto, and banking sectors, with HCL Tech, Tata Motors, and HDFC Life among the heaviest drags. Pharma and metals provided a counterbalance, while broader small-cap indices lost 1%, though more than 130 individual stocks still managed to hit fresh 52-week highs.
The decline has pushed the Nifty into a defined consolidation phase. The index faces immediate resistance near its 20-day moving average around 24,500, with strong support established between 23,800 and 23,950. Options data indicates a max pain point of 24,050 and a put-call ratio of 1.05, suggesting traders expect the sideways churn to persist until the index clears 24,300.
Stock-specific opportunities emerge
Amid this broader indecision, some market participants are identifying localized technical breakouts. Raja Venkatraman, co-founder of NeoTrader, highlighted three stocks showing independent momentum.
SBI Cards and Payment Services is targeting a move to ₹695 from a current level near ₹639, with a stop loss at ₹620. The credit card issuer, which has over 22 million cards in force, recently formed a bullish candle following a consolidation period, aided by news of a potential stake sale.
Telecommunications provider Bharti Hexacom is similarly flagged for a breakout above ₹1625, aiming for ₹1775 over two months. The stock is showing signs of a firming trend after a six-month decline and a recent move out of its cloud region on the charts.
Diagnostic firm Dr. Lal PathLabs, trading near ₹1,745, is targeting ₹1,900 as momentum indicators signal a recovery. The stock has been consistently driving higher from key support levels, indicating an upward trajectory.
All three targets carry defined market risks, from macroeconomic vulnerability for SBI Cards to pricing pressures for Dr. Lal PathLabs. However, their technical positioning illustrates how traders are navigating a market where broad index gains are currently stalled by external energy and global factors.
